31187188|t|Andrographolide enhances hippocampal BDNF signaling and suppresses neuronal apoptosis, astroglial activation, neuroinflammation, and spatial memory deficits in a rat model of chronic cerebral hypoperfusion.
31187188|a|Andrographolide is a medical herbal compound with documented anti-inflammatory activity and therapeutic efficacy in animal models of Alzheimer's disease, traumatic brain injury, and ischemic stroke. The present study examined the potential therapeutic effects of andrographolide on chronic cerebral hypoperfusion (CCH)-induced hippocampal neuronal damage and cognitive dysfunction. A CCH model was established in male Sprague Dawley (SD) rats using 2-vessel occlusion (2VO). After 4 weeks of CCH, spatial learning and memory were assessed in the Morris water maze and structural damage to the hippocampus by hematoxylin and eosin (HE) staining. Astrocyte activation was examined by immunohistochemical staining and Western blotting for glial fibrillary acid protein (GFAP), while expression levels of the pro-inflammatory cytokine-tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1beta), the apoptosis effector cysteinyl aspartate specific proteinase-3 (caspase-3), and the neuroprotectant brain-derived neurotrophic factor (BDNF) and the TrkB receptor were estimated by Western blotting. After 4 weeks of CCH, the hippocampus of 2VO rats exhibited marked neurodegeneration as well as elevated GFAP, TNF-alpha, IL-1beta, and caspase-3 compared to Sham controls. In addition, spatial learning was impaired compared to Sham controls. Andrographolide treatment during CCH suppressed astrocyte activation as evidenced by reduced GFAP expression, enhanced expression of BDNF and TrkB, improved impaired spatial learning and memory, and reversed upregulated TNF-alpha, IL-1beta, and caspase-3 expression. These results reveal a potential neuroprotective effect of andrographolide on hippocampal neuronal damage and cognitive impairment from CCH due to suppression of astrocyte activation and enhancement of BDNF-TrkB signaling.
31187188	0	15	Andrographolide	Chemical	MESH:C030419
31187188	37	41	BDNF	Gene	24225
31187188	110	127	neuroinflammation	Disease	MESH:D000090862
31187188	141	156	memory deficits	Disease	MESH:D008569
31187188	162	165	rat	Species	10116
31187188	175	205	chronic cerebral hypoperfusion	Disease	MESH:D006521
31187188	207	222	Andrographolide	Chemical	MESH:C030419
31187188	273	285	inflammatory	Disease	MESH:D007249
31187188	340	359	Alzheimer's disease	Disease	MESH:D000544
31187188	361	383	traumatic brain injury	Disease	MESH:D000070642
31187188	389	404	ischemic stroke	Disease	MESH:D002544
31187188	470	485	andrographolide	Chemical	MESH:C030419
31187188	489	519	chronic cerebral hypoperfusion	Disease	MESH:D006521
31187188	521	524	CCH	Disease	MESH:D006521
31187188	546	561	neuronal damage	Disease	MESH:D009410
31187188	566	587	cognitive dysfunction	Disease	MESH:D003072
31187188	591	594	CCH	Disease	MESH:D006521
31187188	645	649	rats	Species	10116
31187188	656	674	2-vessel occlusion	Disease	MESH:D065708
31187188	676	679	2VO	Disease	MESH:D065708
31187188	699	702	CCH	Disease	MESH:D006521
31187188	815	826	hematoxylin	Chemical	MESH:D006416
31187188	831	836	eosin	Chemical	MESH:D004801
31187188	838	840	HE	Chemical	-
31187188	943	972	glial fibrillary acid protein	Gene	24387
31187188	974	978	GFAP	Gene	24387
31187188	1016	1028	inflammatory	Disease	MESH:D007249
31187188	1038	1065	tumor necrosis factor alpha	Gene	24835
31187188	1067	1076	TNF-alpha	Gene	24835
31187188	1082	1100	interleukin 1 beta	Gene	24494
31187188	1102	1110	IL-1beta	Gene	24494
31187188	1215	1248	brain-derived neurotrophic factor	Gene	24225
31187188	1250	1254	BDNF	Gene	24225
31187188	1331	1334	CCH	Disease	MESH:D006521
31187188	1355	1358	2VO	Disease	MESH:D065708
31187188	1359	1363	rats	Species	10116
31187188	1381	1398	neurodegeneration	Disease	MESH:D019636
31187188	1419	1423	GFAP	Gene	24387
31187188	1425	1434	TNF-alpha	Gene	24835
31187188	1436	1444	IL-1beta	Gene	24494
31187188	1557	1572	Andrographolide	Chemical	MESH:C030419
31187188	1590	1593	CCH	Disease	MESH:D006521
31187188	1650	1654	GFAP	Gene	24387
31187188	1690	1694	BDNF	Gene	24225
31187188	1699	1703	TrkB	Gene	25054
31187188	1714	1743	impaired spatial learning and	Disease	MESH:D007859
31187188	1777	1786	TNF-alpha	Gene	24835
31187188	1788	1796	IL-1beta	Gene	24494
31187188	1883	1898	andrographolide	Chemical	MESH:C030419
31187188	1914	1929	neuronal damage	Disease	MESH:D009410
31187188	1934	1954	cognitive impairment	Disease	MESH:D003072
31187188	1960	1963	CCH	Disease	MESH:D006521
31187188	2026	2030	BDNF	Gene	24225
31187188	2031	2035	TrkB	Gene	25054
31187188	Positive_Correlation	MESH:D006521	24387
31187188	Negative_Correlation	MESH:C030419	24835
31187188	Association	MESH:D009410	24225
31187188	Association	MESH:D006521	25054
31187188	Positive_Correlation	MESH:D006521	24835
31187188	Positive_Correlation	MESH:D065708	24835
31187188	Negative_Correlation	MESH:C030419	MESH:D007249
31187188	Negative_Correlation	MESH:C030419	MESH:D000070642
31187188	Negative_Correlation	MESH:C030419	24494
31187188	Negative_Correlation	MESH:C030419	MESH:D009410
31187188	Positive_Correlation	MESH:C030419	24225
31187188	Association	24225	25054
31187188	Positive_Correlation	MESH:D065708	24494
31187188	Negative_Correlation	MESH:C030419	MESH:D000090862
31187188	Positive_Correlation	MESH:C030419	25054
31187188	Positive_Correlation	MESH:D065708	24387
31187188	Association	MESH:D006521	24225
31187188	Positive_Correlation	MESH:D006521	24494
31187188	Negative_Correlation	MESH:C030419	MESH:D000544
31187188	Association	MESH:D003072	24225
31187188	Association	MESH:D007249	24494
31187188	Positive_Correlation	MESH:C030419	MESH:D007859
31187188	Association	MESH:D009410	25054
31187188	Negative_Correlation	MESH:C030419	MESH:D006521
31187188	Negative_Correlation	MESH:C030419	24387
31187188	Association	MESH:D003072	25054
31187188	Negative_Correlation	MESH:C030419	MESH:D002544
31187188	Negative_Correlation	MESH:C030419	MESH:D003072
31187188	Negative_Correlation	MESH:C030419	MESH:D008569

